93 related articles for article (PubMed ID: 12048797)
1. [Some pathogenetic aspects of developing liver failure and preventing it in patients with liver cirrhosis after portosystemic shunting].
Nazyrov FG; Akilov KhA; Ibadov RA; Asabaev ASh; Zaĭnutdinov UI; Khafizov BB
Vestn Khir Im I I Grek; 2002; 161(1):87-90. PubMed ID: 12048797
[TBL] [Abstract][Full Text] [Related]
2. The influence of portosystemic shunting on zinc and vitamin A metabolism in liver cirrhosis.
Schölmerich J; Becher MS; Köttgen E; Rauch N; Häussinger D; Löhle E; Vuilleumier JP; Gerok W
Hepatogastroenterology; 1983 Aug; 30(4):143-7. PubMed ID: 6685108
[TBL] [Abstract][Full Text] [Related]
3. Preoperative liver biopsy and survival after portasystemic shunting.
Lang AP; Patel S; Langer B; Phillips MJ
Can J Surg; 1981 Sep; 24(5):543-5. PubMed ID: 7284921
[TBL] [Abstract][Full Text] [Related]
4. [The results of porto-systemic shunting in patients with liver cirrhosis].
Nazyrov FG; Deviatov AV; Ibadov RA; Khashimov ShKh
Khirurgiia (Mosk); 2008; (10):32-5. PubMed ID: 19008812
[TBL] [Abstract][Full Text] [Related]
5. Portosystemic myelopathy: spastic paraparesis after portosystemic shunting.
Conn HO; Rössle M; Levy L; Glocker FX
Scand J Gastroenterol; 2006 May; 41(5):619-25. PubMed ID: 16638707
[TBL] [Abstract][Full Text] [Related]
6. [The partial portosystemic shunting and its hemodynamic consequences].
Shalimov AA; Kalita NIa; Kotenko OG
Klin Khir; 2000 May; (5):5-7. PubMed ID: 11288249
[TBL] [Abstract][Full Text] [Related]
7. [Use of the glue composition TachoComb in forming the portosystemic anastomosis].
Akilov KhA; Deviatov AV; Ibadov RA; Zaĭnutdinov UI; Ikramov AI
Vestn Khir Im I I Grek; 2001; 160(2):87-9. PubMed ID: 11496501
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 activity mirrors nitric oxide levels in postoperative sepsis: predictive indicators of lethal outcome.
Novotny AR; Emmanuel K; Maier S; Westerholt A; Weighardt H; Stadler J; Bartels H; Schwaiger M; Siewert JR; Holzmann B; Heidecke CD
Surgery; 2007 Mar; 141(3):376-84. PubMed ID: 17349850
[TBL] [Abstract][Full Text] [Related]
9. Role of surgical portosystemic shunts in the era of interventional radiology and liver transplantation.
Orug T; Soonawalla ZF; Tekin K; Olliff SP; Buckels JA; Mayer AD
Br J Surg; 2004 Jun; 91(6):769-73. PubMed ID: 15164449
[TBL] [Abstract][Full Text] [Related]
10. Impact of prior portosystemic shunt procedures on outcome of liver transplantation.
Dell'Era A; Grande L; Barros-Schelotto P; Turnes J; Fuster J; Charco R; García-Valdecasas JC; Bosch J; García-Pagán JC
Surgery; 2005 Jun; 137(6):620-5. PubMed ID: 15933628
[TBL] [Abstract][Full Text] [Related]
11. Cerebral edema and hyperammonemia after transjugular intrahepatic portosystemic shunt placement in a cirrhotic patient.
Kavitt RT; Yang VL; Jensen DM
Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1054-6. PubMed ID: 18603480
[TBL] [Abstract][Full Text] [Related]
12. [Curve of plasma disappearance of bromosulfophthalein after a single injection. Control of cirrhosis patients after elective portosystemic derivation].
Zotti S; Turrin M; Gerunda G; Maffei Faccioli A; Ghidini O
Minerva Chir; 1984 Jun; 39(11):887-96. PubMed ID: 6483219
[No Abstract] [Full Text] [Related]
13. Factors predicting early postoperative liver cirrhosis-related complications after lung cancer surgery in patients with liver cirrhosis.
Iwata T; Inoue K; Nishiyama N; Nagano K; Izumi N; Tsukioka T; Hanada S; Suehiro S
Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):720-30. PubMed ID: 17766277
[TBL] [Abstract][Full Text] [Related]
14. Distal splenorenal shunt: preferred treatment for recurrent variceal hemorrhage in the patient with well-compensated cirrhosis.
Elwood DR; Pomposelli JJ; Pomfret EA; Lewis WD; Jenkins RL
Arch Surg; 2006 Apr; 141(4):385-8; discussion 388. PubMed ID: 16618897
[TBL] [Abstract][Full Text] [Related]
15. Lack of increase in insulin resistance after portosystemic surgical shunt in patients with cirrhosis.
Cavallo-Perin P; Bruno A; Nuccio P; Dall'omo AM; Pagano G; Robecchi A
N Engl J Med; 1985 Jun; 312(26):1709-10. PubMed ID: 4000220
[No Abstract] [Full Text] [Related]
16. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
17. Assessment of prognosis of cirrhosis.
Durand F; Valla D
Semin Liver Dis; 2008 Feb; 28(1):110-22. PubMed ID: 18293281
[TBL] [Abstract][Full Text] [Related]
18. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors.
Paugam-Burtz C; Kavafyan J; Merckx P; Dahmani S; Sommacale D; Ramsay M; Belghiti J; Mantz J
Liver Transpl; 2009 May; 15(5):522-9. PubMed ID: 19399736
[TBL] [Abstract][Full Text] [Related]
19. [Changes in renal function in patients with severe hepatitis and liver cancer with cirrhosis during orthotopic liver transplantation].
Li XY; Hei ZQ; Li SR; Shen N
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):386-9. PubMed ID: 17631701
[TBL] [Abstract][Full Text] [Related]
20. [Results of partial shunting in liver cirrhosis].
Kalita NIa; Kotenko OG; Andreeshchev SA
Klin Khir; 2000 Jun; (6):10-3. PubMed ID: 11288266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
